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Treatment of an Axillary Artery Pseudoaneursym using Balloon
Protection and an Ethylene Vinyl Alcohol Copolymer (Onyx)
A.J. Ling,* R. Pathak, S. Nadkarne and M. Garbowski
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
The development of an iatrogenic pseudoaneurysm is a recognised risk following arterial puncture. Management options
include surgery, use of covered stents, ultrasound-guided compression and percutaneous injection of a thrombotic sub-
stance such as thrombin. This paper describes an alternative technique using balloon protection and the percutaneous
injection of an ethylene vinyl alcohol copolymer, Onyx (Micro Therapeutics, Inc, Irvine, CA) under ultrasound guidance.
This provides a safe and controlled method to occlude the pseudoaneurysm. The advantages of Onyx over other treatment
methods are discussed.
Keywords: Axillary artery pseudoaneurysm; Ethylene vinyl alcohol copolymer; Iatrogenic pseudoaneurysm.Introduction
Pseudoaneurysms (also known as false aneursyms,
pulsatile or communicating haematomas) form from
arterial puncture sites that fail to form an adequate
seal post catheter removal. They can also form from
inflammation, trauma and neoplasms. Most recent
papers report an iatrogenic incidence of pseudoaneur-
ysm formation in 0.6%e6.0% of patients.1
Several treatment options exist. Traditional surgical
treatment or conservative compression has pro-
gressed to compression with ultrasound guidance
and injection of a thrombosing agent. This paper dis-
cusses the use of balloon protection with the injection
of an embolic agent, Onyx, in the treatment of an
axillary artery pseudoaneurysm.
Case Report
A 60 year old male was admitted with deteriorating
liver function post liver transplant. Past history in-
cluded hepatitis C, alcohol abuse and peptic ulcer
disease. Radiological investigation showed stenosis
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diagnosis of ischaemic hepatitis was made.
Due to inability to gain access into the coeliac trunk
using a femoral approach, a left axillary artery punc-
ture was performed with successful coeliac trunk can-
nulation using a 55 cm 6F Cobra (Cordis Inc) catheter.
The lumen was dilated to 5 mm. Manual pressure to
the left axillary artery puncture was applied with
the aid of Syvek Patches (Medtel Australia Pty Ltd),
taking 35 minutes of high-grade compression to
achieve external haemostasis.
Within 12 hours, the patient developed increasing
pulsatile swelling of his left axilla and symptoms
and signs of brachial plexus compression. Ultrasound
confirmed the presence of a pseudoaneurysm in the
left axillary artery, measuring 24 mm with a wide
neck. Given the patient’s coagulopathy and high sur-
gical risk, a percutaneous approach at excluding the
pseudoaneurysm was chosen (Fig. 1).
Using a left common femoral artery puncture, a 7F
100 cm Arrow Sheath was introduced. Angiography
confirmed the presence of a pseudoaneurysm with
a wide neck. Attempts at selectively catheterising the
pseudoaneurysm via an intra-arterial approach were
unsuccessful. Due to its wide neck, balloon occlusion
was performed using a 5 mme20 mm Gazelle
(Boston Scientific) followed by ultrasound-guided
puncture of the pseudoaneurysm using a micro
56 A. J. Ling et al.puncture needle. Onyx was infused into the lumen of
the pseudoaneurysm directly. See Fig. 2.
Ultrasound showed almost immediate cessation of
flow post injection. The balloon was deflated after two
minutes, and an angiogram was performed, which
showed no flow into the pseudoaneurysm. See Fig. 3.
A follow up scan 24 hours later showed normal
flow through the brachial, radial and ulnar arteries,
with no residual flow in the pseudoaneurysm
(Figs. 4 and 5).
The patient made full recovery, with rapid resolu-
tion of neurological symptoms and signs.
Discussion
Numerous suitable options exist for the treatment
of pseudoaneurysms. Observation and compression
therapy e either direct or ultrasound-guided e are
Fig. 1. Ultrasound of the left axillary artery
pseudoaneurysm.
Fig. 2. DSA of pseudoaneurysm.EJVES Extra Vol 12, October 2006more suited for the management of pseudoaneurysms
involving superficial arteries. For deeper vessels,
alternatives to surgery include covered stents and
endovascular embolisation, using one of several em-
bolic agents e coils, N-Butyl cyanoacrylate (NBCA),
autologous clot, Gelfoam (Pharmacia and Upjohn,
Kalamazoo, MI), and thrombin.
Most investigators have agreed that coils are most
appropriate for pseudoaneurysms that have ruptured,
however this is not applicable to large pseudoaneur-
ysms.2 Thrombin is available several forms. Bovine
thrombin carries the risk of anaphylaxis, as well as
the risk of transmission of bovine spongiform enceph-
alopathy. The authors have had experience with ana-
phylaxis from thrombin, but these complications are
less common than distal embolisation, which occurs
in 2% of those treated with percutaneous thrombin
Fig. 3. Balloon occlusion (large arrow) with percutaneous
injection of Onyx (solid arrow).
Fig. 4. Injection of Onyx has successfully occluded the
pseudoaneurysm.
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meant that use of thrombin may have resulted in dis-
tal embolisation of the many collaterals of the axillary
artery, which would not have been visualised and
recognised.
In the case described, the use of a new agent Onyx
(Micro Therapeutics, Inc, Irvine, CA) allows a more
deliberate and controlled thrombosis procedure.
Onyx is a liquid embolic material made of an ethylene
vinyl alcohol copolymer dissolved in the organic sol-
vent, dimethyl sulfoxide (DMSO). When the material
comes into contact with an aqueous solution, it pre-
cipitates and forms a soft spongy polymer cast that
does not adhere to the vascular wall.3
Controlled, deliberate and predictable thrombosis
is achieved for several reasons. Radio-opaque micron-
ised tantalum powder allows easy visualisation.
Precipitation only occurs in the absence of DMSO,
hence by preloading the microcatheters with DMSO,
it prevents undesired cementing of the catheter tip
in vessels or adhesion of catheter tips to the endothe-
lial wall. The liquid nature allows cast formation of
Fig. 5. Post-procedural ultrasound, showing no flow in the
pseudoaneurysm.the vasculature that needs to be occluded. High vis-
cosity and long polymerisation time allows slower
and controlled administration. Requirements for ad-
ditional embolic agent can be ascertained using trans-
embolisation angiography, which is not possible with
cyanoacrylates.4
Limitations with Onyx include requirements for
good neck coverage and occlusion, as Onyx is non-
adhesive. Hence it is possible that in-flow can dissect
between the cast and the vessel wall, which can be
limited through the use of balloon occlusion. Also,
the persistent mass may impinge on nearby neurovas-
cular structures. However, being non-adhesive, it pre-
serves the option for subsequent surgical resection if
desired, in an easier fashion than the more solidified
acrylate masses.5 Cost-benefit decisions are recom-
mended, with selective use of Onyx where a con-
trolled, deliberate and predictable thrombosis is
required.
In summary, Onyx combined with balloon occlu-
sion of the aneurysmal necks, provides an alterna-
tive safe and controlled management option for
pseudoaneurysms.
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